Trials / Completed
CompletedNCT02671682
Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis
Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis and Clinically Isolated Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Albert Christian Ludolph, Prof. · Academic / Other
- Sex
- All
- Age
- 12 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This observational study investigates the efficacy and safety of immunoadsorption versus plasmapheresis in 60 patients with relapse in Multiple Sclerosis and Clinically isolated syndrome who do not fully recover after a high doses of intravenous corticosteroids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Immunoadsorption | |
| PROCEDURE | Plasmapheresis |
Timeline
- Start date
- 2016-02-26
- Primary completion
- 2019-01-03
- Completion
- 2019-01-25
- First posted
- 2016-02-02
- Last updated
- 2019-09-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02671682. Inclusion in this directory is not an endorsement.